GRTX Annual Retained Earnings
-$437.41 M
-$59.08 M-15.62%
31 December 2023
Summary:
As of January 23, 2025, GRTX annual retained earnings is -$437.41 million, with the most recent change of -$59.08 million (-15.62%) on December 31, 2023. During the last 3 years, it has fallen by -$201.84 million (-85.68%). GRTX annual retained earnings is now -474.76% below its all-time high of -$76.10 million, reached on December 31, 2017.GRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Quarterly Retained Earnings
-$451.43 M
-$5.58 M-1.25%
01 September 2024
Summary:
As of January 23, 2025, GRTX quarterly retained earnings is -$451.43 million, with the most recent change of -$5.58 million (-1.25%) on September 1, 2024. Over the past year, it has dropped by -$14.03 million (-3.21%). GRTX quarterly retained earnings is now -330.66% below its all-time high of -$104.82 million, reached on December 31, 2018.GRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.6% | -3.2% |
3 y3 years | -85.7% | -3.2% |
5 y5 years | -317.3% | -3.2% |
GRTX Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -38.4% | at low | -42.8% | at low |
5 y | 5-year | -171.1% | at low | -179.8% | at low |
alltime | all time | -474.8% | at low | -330.7% | at low |
Galera Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$451.43 M(+1.3%) |
June 2024 | - | -$445.85 M(+0.9%) |
Mar 2024 | - | -$441.79 M(+1.0%) |
Dec 2023 | -$437.41 M(+15.6%) | -$437.41 M(+1.3%) |
Sept 2023 | - | -$431.82 M(+3.6%) |
June 2023 | - | -$416.75 M(+5.2%) |
Mar 2023 | - | -$396.03 M(+4.7%) |
Dec 2022 | -$378.32 M(+19.7%) | -$378.32 M(+4.5%) |
Sept 2022 | - | -$362.14 M(+4.6%) |
June 2022 | - | -$346.10 M(+4.4%) |
Mar 2022 | - | -$331.55 M(+4.9%) |
Dec 2021 | -$316.10 M | -$316.10 M(+5.6%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | -$299.30 M(+8.2%) |
June 2021 | - | -$276.67 M(+8.8%) |
Mar 2021 | - | -$254.28 M(+7.9%) |
Dec 2020 | -$235.57 M(+46.0%) | -$235.57 M(+9.3%) |
Sept 2020 | - | -$215.50 M(+8.6%) |
June 2020 | - | -$198.42 M(+10.4%) |
Mar 2020 | - | -$179.77 M(+11.4%) |
Dec 2019 | -$161.35 M(+53.9%) | -$161.35 M(+11.5%) |
Sept 2019 | - | -$144.68 M(+11.5%) |
June 2019 | - | -$129.74 M(+23.8%) |
Dec 2018 | -$104.82 M(+37.7%) | -$104.82 M |
Dec 2017 | -$76.10 M | - |
FAQ
- What is Galera Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Galera Therapeutics?
- What is Galera Therapeutics annual retained earnings year-on-year change?
- What is Galera Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Galera Therapeutics?
- What is Galera Therapeutics quarterly retained earnings year-on-year change?
What is Galera Therapeutics annual retained earnings?
The current annual retained earnings of GRTX is -$437.41 M
What is the all time high annual retained earnings for Galera Therapeutics?
Galera Therapeutics all-time high annual retained earnings is -$76.10 M
What is Galera Therapeutics annual retained earnings year-on-year change?
Over the past year, GRTX annual retained earnings has changed by -$59.08 M (-15.62%)
What is Galera Therapeutics quarterly retained earnings?
The current quarterly retained earnings of GRTX is -$451.43 M
What is the all time high quarterly retained earnings for Galera Therapeutics?
Galera Therapeutics all-time high quarterly retained earnings is -$104.82 M
What is Galera Therapeutics quarterly retained earnings year-on-year change?
Over the past year, GRTX quarterly retained earnings has changed by -$14.03 M (-3.21%)